FDA provides an update on its ongoing monitoring of heater-cooler devices and the risk of nontuberculous mycobacteria infections in patients who have ...
FDA warns Smitha Reddy and her Poway, CA-based ACRC Studies facility about objectionable conditions in conducting two clinical investigations.
FDA warns Deerfield Beach, FL-based Hybrid Pharma about multiple violations in its work as an outsourcing facility.
FDA approves an Alnylam Pharmaceuticals NDA for Amvuttra (vutrisiran), an RNAi therapeutic administered by subcutaneous injection once every three mon...
Troutman Pepper attorneys discuss a new FDA draft guidance giving sponsors information on presenting diversity plans to enroll under-represented popul...
The presiding officer for a hearing on a CDER proposal to withdraw approval for Covis Makena says the hearing will be held 10/17-10/19.
A Brookings Institution white paper lists six policy changes FDA could make to enhance generic drug competition.
FDA commissioner Robert Califf says a total revamp of the drug accelerated approval program is not needed to answer criticism following a number of dr...